A case of immune-related bronchial asthma newly developed following the initiation of nivolumab and ipilimumab combination therapy for malignant pleural mesothelioma, successfully treated with mepolizumab
Published: November 10, 2023Received: June 12, 2023Available on J-STAGE: July 07, 2025Accepted: August 10, 2023
Advance online publication: -
Revised: -